Which LABA can be combined with Budesonide in asthma therapy?

Formoterol is the correct choice for combination with Budesonide in asthma therapy because it is a long-acting beta-agonist (LABA) that has been specifically approved for use in conjunction with inhaled corticosteroids like Budesonide. This combination is effective in managing asthma by providing both anti-inflammatory effects from the corticosteroid and bronchodilation from the LABA, leading to improved symptom control and reduced exacerbation frequency.

Inhaled corticosteroids are essential in controlling underlying airway inflammation in asthma, while LABAs offer prolonged bronchodilation. Formoterol’s quick onset of action also allows for effective relief of acute bronchospasm, making it a suitable option for patients requiring both immediate and preventative therapy.

Other options, while important in the context of asthma management, do not represent the correct combination with Budesonide for this specific question. Fluticasone is another inhaled corticosteroid and should not be combined with Budesonide. Salmeterol is another LABA, but it is typically used in combination with other corticosteroids rather than Budesonide. Montelukast, on the other hand, is a leukotriene receptor antagonist and serves a different therapeutic role not involving direct combination with inhaled corticosteroids in a